Table 1.
Characteristics of 1,008 women participating in the study
| Total | Cytology | hrHPV | P‐values by χ2 | ||
|---|---|---|---|---|---|
| n = 1,008 | n = 521(52%) | n = 487 (48%) | |||
| Age | 34–44 years | 301 (30%) | 159 (30%) | 142 (29%) | 0.33 |
| 45–54 years | 343 (34%) | 185 (36%) | 158 (32%) | ||
| 55 years and older | 364 (36%) | 177 (34%) | 187 (39%) | ||
| Marital status1 | Married/Cohabiting/ | 830 (82%) | 441 (85%) | 389 (80%) | 0.04 |
| Single/divorced/widow | 175 (18%) | 78 (15%) | 97 (20%) | ||
| Attained education2 | Up to 13 years | 421 (42%) | 210 (40%) | 211 (43%) | 0.34 |
| More than 13 years | 582 (58%) | 308 (60%) | 274 (57%) | ||
| Years lived in Norway3 | Less than all life | 148 (15%) | 83 (16%) | 65 (13%) | 0.25 |
| All life | 858 (85%) | 437 (84%) | 421 (87%) | ||
| Birthplace | Norway | 917 (91%) | 465 (89%) | 452 (93%) | 0.05 |
| Other countries | 91 (9%) | 56 (11%) | 35 (7%) | ||
| Screening results | Normal screen results | 468 (52%) | 240 (46%) | 228 (47%) | 0.81 |
| Abnormal screen results | 540 (48%) | 281 (54%) | 259 (53%) | ||
| Anxiety and depression4 | Normal scores | 716 (73%) | 370 (73%) | 346 (73%) | 0.88 |
| Mild scores | 206 (21%) | 109 (22%) | 97 (21%) | ||
| Moderate/severe scores | 53 (6%) | 26(5%) | 27 (6%) | ||
| Time between screening and answering questionnaire | 4 months to 1 year | 521 (52%) | 216 (41%) | 227 (47%) | 0.10 |
| 1–2 years | 487 (48%) | 305 (59%) | 260 (53%) | ||
| Knowledge that screening can prevent cervical cancer5 | Yes | 980 (98%) | 503 (97%) | 477 (98%) | 0.30 |
| No | 19 (2%) | 16 (3%) | 10 (2%) | ||
| Knowledge of the link between hrHPV and cervical cancer | Yes | 695 (69%) | 342 (66%) | 353 (72%) | 0.02 |
| No | 313 (31%) | 179 (34%) | 134 (28%) | ||
| Knowledge related to last screening method used6 | Correct | 364 (37%) | 181(35%) | 183 (39%) | 0.00 |
| Not correct | 112(12%) | 18 (4%) | 94 (20%) | ||
| I do not know | 502 (51%) | 307 (61%) | 195 (41%) | ||
| Knowledge related to last screening test results7 | Correct | 698 (74%) | 316 (66%) | 382 (82%) | 0.00 |
| Not correct | 251 (26%) | 166 (34%) | 85 (18%) | ||
| If the screening interval is extended from 3 to 5 years, I would take an addition screening test on my own initiative: | More often (>5 years) | 557 (56%) | 277 (53%) | 280 (58%) | 0.292 |
| Rarer (<5 years) | 15 (1%) | 6 (1%) | 9 (2%) | ||
| When reminder from CRN | 352 (35%) | 189 (36%) | 163 (33%) | ||
| Never or not sure | 84 (8%) | 49 (10%) | 35 (7%) | ||
1
3 missing.
2
5 missing.
3
2 missing.
4
33 missing.
5
9 missing.
6
30 missing.
7
59 missing.
Abbreviations: CRN: Cancer Registry of Norway; hrHPV: high‐risk human papilloma virus.